Creative Biomolecules Overview
- Year Founded
-
1982
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
Creative Biomolecules General Information
Description
Operator of a biopharmaceutical company focused on the discovery and development of therapies for human tissue regeneration and repair. The Company's therapies are based on bone morphogenetic proteins (BMPs) that act in initiating and regulating the cellular events involved in the development and repair of human tissues and organs. Its bone graft substitute is designed to promote new bone growth to heal severe fractures.
Contact Information
Website
www.creativebio.comCorporate Office
- 45 South Street
- Hopkinton, MA 01748
- United States
Corporate Office
- 45 South Street
- Hopkinton, MA 01748
- United States
Creative Biomolecules Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 31-Jul-2000 | Completed | Profitable | |||
| 6. PIPE | 29-May-1998 | Completed | Profitable | |||
| 5. 2PO | 03-Jul-1996 | Completed | Profitable | |||
| 4. IPO | 01-Dec-1992 | Completed | Profitable | |||
| 3. Later Stage VC | 30-Oct-1991 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 04-Sep-1989 | $7.5M | $10.2M | Completed | Generating Revenue | |
| 1. Later Stage VC | 18-May-1987 | $2.7M | $2.7M | Completed | Generating Revenue |
Creative Biomolecules Comparisons
Industry
Financing
Details
Creative Biomolecules Competitors (9)
One of Creative Biomolecules’s 9 competitors is Agomab Therapeutics, a Formerly VC-backed company based in Antwerp, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agomab Therapeutics | Formerly VC-backed | Antwerp, Belgium | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| GeneCast Biotechnology | Private Equity-Backed | Wuxi, China | ||||
| Cellmade | Private Equity-Backed | Ruffieux, France |
Creative Biomolecules Patents
Creative Biomolecules Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20080167225-A1 | Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue, repairing a defect in an intervertebral disc | Active | 30-Jul-1999 | ||
| US-7572440-B2 | Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue, repairing a defect in an intervertebral disc | Inactive | 30-Jul-1999 | ||
| WO-2000066620-A2 | Morphogen-induced enhancement of fertility | Inactive | 30-Apr-1999 | ||
| WO-2000066620-A3 | Morphogen-induced enhancement of fertility | Inactive | 30-Apr-1999 | ||
| WO-2000029012-A2 | Methods of alleviating cancer symptoms | Inactive | 13-Nov-1998 | C07K14/51 |
Creative Biomolecules Signals
Creative Biomolecules Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apax Partners | PE/Buyout | Minority | ||
| Banexi Ventures Partners | Venture Capital | Minority | ||
| Diaz & Altschul Advisors | Corporate Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Marion Laboratories | Corporation | Minority |
Creative Biomolecules Investments & Acquisitions (2)
Creative Biomolecules’s most recent deal was a Reverse Merger with Curis. The deal was made on 31-Jul-2000.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Curis | 31-Jul-2000 | Reverse Merger | Biotechnology | ||
| Exelixis | 01-Mar-1995 | Early Stage VC | Drug Discovery |
Creative Biomolecules FAQs
-
When was Creative Biomolecules founded?
Creative Biomolecules was founded in 1982.
-
Where is Creative Biomolecules headquartered?
Creative Biomolecules is headquartered in Hopkinton, MA.
-
What is the size of Creative Biomolecules?
Creative Biomolecules has 40 total employees.
-
What industry is Creative Biomolecules in?
Creative Biomolecules’s primary industry is Drug Discovery.
-
Is Creative Biomolecules a private or public company?
Creative Biomolecules is a Private company.
-
What is Creative Biomolecules’s current revenue?
The current revenue for Creative Biomolecules is .
-
How much funding has Creative Biomolecules raised over time?
Creative Biomolecules has raised $85.7M.
-
Who are Creative Biomolecules’s investors?
Apax Partners, Banexi Ventures Partners, Diaz & Altschul Advisors, Domain Associates, and Marion Laboratories have invested in Creative Biomolecules.
-
Who are Creative Biomolecules’s competitors?
Agomab Therapeutics, Inovio Pharmaceuticals, Sangamo Therapeutics, GeneCast Biotechnology, and Cellmade are some of the 9 competitors of Creative Biomolecules.
-
When was Creative Biomolecules acquired?
Creative Biomolecules was acquired on 31-Jul-2000.
-
Who acquired Creative Biomolecules?
Creative Biomolecules was acquired by Curis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process